There are many risk factors for developing postoperative nausea and vomiting (PONV), but a simplified risk score can help with assessing those risk factors, said Jawad N. Saleh, PharmD, BSPharm, BCCCP, BCPS, clinical manager of pharmacy services, Hospital for Special Surgery.
There are many risk factors for developing postoperative nausea and vomiting (PONV), but a simplified risk score can help with assessing those risk factors, said Jawad N. Saleh, PharmD, BSPharm, BCCCP, BCPS, clinical manager of pharmacy services, Hospital for Special Surgery.
Transcript
What are some of the most common risk factors for postoperative nausea and vomiting? How should these risks be assessed to understand treatment?
The risk factors are vast. If you look into it, there's so many risk factors. But based on the Apfel study, if you look at the Apfel simplified risk score—which I actually encourage and it's also encouraged in the consensus guidelines that were recently published—if you're female, that's a risk factor. If you are a nonsmoker, that's a risk factor. If you have a history of PONV or motion sickness, that's a risk factor. And if you're getting opioids, that's a risk factor.
So those are the 4 Apfel simplified risk factors and, honestly, it puts a large number of people in more of a moderate- or high-risk state of PONV. Keeping that in mind, the average PONV rate is 30%; it’s 80% for high-risk patients. At Hospital for Special Surgery, we've been doing an amazing job—we're well below that number. And hopefully, we continue to reduce that number.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
April 2nd 2025Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as explored by speakers at the Academy of Managed Care Pharmacy’s annual meeting.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More